semaglutide going off the market Size, Share & Trends Report, 2025-2035 Semaglutide Market Share, Size &

For a temperature-sensitive medication like semaglutide, shipping delays raise storage and stability concerns

If you have specific health concerns or queries, Apka Muaalij encourages you to consult your qualified specialists

Pouleur, S., Richard, C., Martin, J.-G

Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).